Kimyon, GezmisKiraz, SedatErtenli, IhsanKucuksahin, OrhanDalkilic, EdizBes, CemalKanitez, Nilufer AlpayKasifoglu, TimucinEmmungil, HakanCoskun, Belkis NihanYagiz, BurcuKoca, Suleyman SerdarCinar, MuhammetAtes, AskinAkar, ServetBakirli, Duygu ErsozluYazisiz, VeliBilge, Nazife Sule YasarTufan, Muge AydinKaradag, OmerKelesoglu, Ayse BaharMercan, RidvanGercik, OnayOz, BurakAkar, Zeynel AbidinYilmaz, SedatTuran, SezinPehlivan, YavuzTerzioglu, EnderKilic, LeventErten, SukranTekgoz, EmreTascilar, KorayKalyoncu, Umut2023-04-192023-04-1920182326-5191http://hdl.handle.net/11727/8835enginfo:eu-repo/semantics/closedAccessLeflunomide As a Concomitant DMARD Choice for the Biological Treatment Era of Rheumatoid ArthritisConference Object70551000447268901084